Glioblastoma

Kyung-Hee Kim1, Simona Migliozzi2, Harim Koo3

  • 1Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea; Proteomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang, Korea.

Cancer cell
|January 12, 2024
PubMed
概括

质母细胞瘤 (GBM) 超越了基因,在复发性瘤中转变为具有WNT/PCP和BRAF激活的神经元状态. 与泰莫索洛米德 (TMZ) 结合的BRAF抑制显示出对抗GBM进展的前景.